Yüklüyor......
Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer’s disease
BACKGROUND: Kallikrein 6 (KLK6) is known to be an age-related protease expressed at high levels in the central nervous system. It was previously shown to be involved in proteolysis of extracellular proteins implicated in neurodegenerative diseases such as Alzheimer’s disease (AD), prompting validati...
Kaydedildi:
| Yayımlandı: | Alzheimers Res Ther |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5789599/ https://ncbi.nlm.nih.gov/pubmed/29378650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-018-0336-4 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|